Eton Pharmaceuticals Announces Third Quarter 2020 Financial Results
12 nov. 2020 16h05 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 12, 2020
04 nov. 2020 16h05 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Closing of Public Offering
16 oct. 2020 16h05 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
15 oct. 2020 08h30 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Prices Underwritten Public Offering of Common Stock
14 oct. 2020 08h30 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
13 oct. 2020 16h01 HE
|
Eton Pharmaceuticals
DEER PARK, Ill. , Oct. 13, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for...
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
08 oct. 2020 08h00 HE
|
Eton Pharmaceuticals
- Application Assigned a PDUFA Date of May 27, 2021 - Dehydrated Alcohol Injection Market Estimated to be Greater Than $100 Million Annually - Application has Received Orphan Drug Designation for...
Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (ET-101)
06 oct. 2020 16h05 HE
|
Eton Pharmaceuticals
- Application Submitted for the Treatment of Partial-Onset Seizures and Migraine - Eton’s Patent-Pending Product Addresses Significant Unmet Need for a Liquid Formulation of Topiramate - Topiramate...
Eton Pharmaceuticals Announces FDA Approval of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency
29 sept. 2020 18h50 HE
|
Eton Pharmaceuticals
-ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for adrenocortical insufficiency specifically designed for children -Eton expects ALKINDI SPRINKLE to be...
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
16 sept. 2020 09h00 HE
|
Eton Pharmaceuticals
DEER PARK, Ill., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...